Here are five highlights:
1. ReBOSSIS is the sole biosynthetic bone scaffold with electrospun microfiber construction.
2. The product is designed for posterolateral spine procedures.
3. ReBOSSIS has yielded a 54 percent compression recovery rate.
4. Providers have used ReBOSSIS in more than 1,500 procedures.
5. ORTHOReBIRTH USA is a wholly owned subsidiary of ORTHOReBIRTH Co.
More articles on biologics:
Kleiner Device Labs unveils new spinal bone graft tool: 5 things to know
GI surgical sealant receives CE marking for sale in the EU — 5 insights
1st surgery to treat damaged cartilage with allogeneic stem cells in Japan — 6 key insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.